Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
about
Steroids for idiopathic sudden sensorineural hearing lossSteroids for idiopathic sudden sensorineural hearing lossSustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses.Evaluation of the endothelial cell antibodies in serum and perilymphatic fluid of cochlear implanted children with sensorineural hearing loss.Combined intratympanic and systemic steroid therapy for poor-prognosis sudden sensorineural hearing loss.Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration.Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation.Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss.Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.Intratympanic dexamethasone in sudden sensorineural hearing loss: A systematic review and meta-analysis.Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss.Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD.Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic.Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.Intratympanic steroids for sudden sensorineural hearing loss: a systematic review.Preoperative steroids for hearing preservation cochlear implantation: A review.Dexamethasone eluting cochlear implant: Histological study in animal model.Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.Noninvasive intratympanic dexamethasone treatment for sudden sensorineural hearing loss.Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial.Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study.Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness.Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.Hearing outcome of sudden sensorineural hearing loss: long-term follow-up.Novel drug delivery systems for inner ear protection and regeneration after hearing loss
P2860
Q24201365-075AB47B-4E44-444F-8F50-D535DE6F763EQ24244649-DF7CA31C-52F7-41F0-B96E-5CF42CDED50FQ30392675-EE867B64-A186-4E78-88EB-BC932B92C671Q30428030-D6E34B55-3C4D-4A22-9A6B-D7A4CB625C26Q30446354-CD1E8526-48EB-4AE7-AD80-BCA2F4CE59A0Q30454645-E641047B-7DA6-45F2-9EF8-9149F592CE2DQ30466045-BF2CA939-9109-4A66-B113-9DF59121E386Q34110153-0DAAF944-97FB-46FC-89D3-5A1BCF388986Q35810136-4B154E54-F0BC-4FD3-B34A-1FF406872FC6Q36080545-6F22D00D-B3DB-41B7-8F34-45A10ADD836BQ36197780-31BF48BD-6EDB-46CE-847D-8EE6720C1B3DQ36556937-5BBB6B6D-63B9-40FE-857B-CF9D640EF854Q36815462-C0D3219F-D68F-4CB6-99A6-721A2D8DA1B7Q37541886-9451E307-D790-49B4-A4E8-8C47AD538CD9Q37919754-E1CF8271-F7A4-40ED-B36E-34A51CC0C720Q37923244-903F6B2A-EFF9-4BD9-AEC3-0990A74E1EB5Q38749399-24C7BEE1-476A-4D61-AE75-AB30085A213CQ42502121-6F058F1B-3ECE-4C46-9D0A-CCF9BD5CB119Q43253894-D1194103-FFF5-4FE6-A8D9-9FB065523D02Q45305480-F7399EDD-573F-45E4-B6A6-6961EA63FC55Q45764867-8A361DFC-8C45-40E1-B7C4-853F10F96007Q49921158-7EA221BB-793E-46CA-8E7D-3189454B49E0Q50356944-7D5AF5D2-C40C-41CE-9F97-FA989BA9D423Q50432245-60EFB3E9-2491-4FBB-A9D4-597B60B09325Q50434993-0B950F43-2AE0-4A89-8E8D-523034E93BE5Q50455683-79F8551C-8206-40D5-90D7-4B0A14877DEEQ50456895-DFACEEEE-4EE9-4F95-A408-76052CF32CA5Q50459199-07FAF4C6-9CC8-4B89-B347-08D8627E1792Q58767632-EF613645-757E-43A7-BC88-E5DD86BFADE5
P2860
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@ast
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@en
type
label
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@ast
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@en
prefLabel
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@ast
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@en
P2860
P1476
Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
@en
P2093
Brian D Herr
Sam J Marzo
P2860
P304
P356
10.1016/J.OTOHNS.2004.09.138
P577
2005-04-01T00:00:00Z